...
首页> 外文期刊>Drug development and industrial pharmacy >Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals
【24h】

Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals

机译:四种不同尺寸减小方法对美麦角灵纳米晶体的粒径,溶解度提高和物理稳定性的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Nicergoline, a poorly soluble active pharmaceutical ingredient, possesses vaso-active properties which causes peripheral and central vasodilatation. In this study, nanocrystals of nicergoline were prepared in an aqueous solution of polysorbate 80 (nanosuspension) by using four different laboratory scale size reduction techniques: high pressure homogenization (HPH), bead milling (BM) and combination techniques (high pressure homogenization followed by bead milling HPH + BM, and bead milling followed by high pressure homogenization BM + HPH). Nanocrystals were investigated regarding to their mean particles size, zeta potential and particle dissolution. A short term physical stability study on nanocrystals stored at three different temperatures (4, 20 and 40 degrees C) was performed to evaluate the tendency to change in particle size, aggregation and zeta potential. The size reduction technique and the process parameters like milling time, number of homogenization cycles and pressure greatly affected the size of nanocrystals. Among the techniques used, the combination techniques showed superior and consistent particle size reduction compared to the other two methods, HPH + BM and BM + HPH giving nanocrystals of a mean particle size of 260 and 353 nm, respectively. The particle dissolution was increased for any nanocrystals samples, but it was particularly increased by HPH and combination techniques. Independently to the production method, nicergoline nanocrystals showed slight increase in particle size over the time, but remained below 500 nm at 20 degrees C and refrigeration conditions.
机译:尼麦角林是一种难溶的活性药物成分,具有血管活性,可引起周围和中央血管舒张。在这项研究中,尼麦角林的纳米晶体是通过使用四种不同的实验室规模缩小技术在聚山梨酯80(纳米悬浮液)的水溶液中制备的:高压均质化(HPH),珠磨(BM)和组合技术(高压均质后进行珠磨HPH + BM,然后进行珠磨,然后高压均质BM + HPH)。研究了纳米晶体的平均粒径,ζ电势和粒子溶解度。对存储在三个不同温度(4、20和40摄氏度)的纳米晶体进行了短期物理稳定性研究,以评估粒度,聚集和ζ电位变化的趋势。尺寸减小技术和工艺参数(如研磨时间,均质化循环次数和压力)极大地影响了纳米晶体的尺寸。在所使用的技术中,与其他两种方法(HPH + BM和BM + HPH)相比,组合技术显示出出众的一致的粒径减小,从而分别产生了平均粒径为260和353 nm的纳米晶体。对于任何纳米晶体样品,颗粒溶解度都增加了,但是通过HPH和组合技术,颗粒溶解度特别增加了。与生产方法无关,麦角林碱纳米晶体随时间的推移显示出粒度略有增加,但在20摄氏度和冷藏条件下保持低于500 nm。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号